Clinical Trial Update: Effect of BIBW 2948 BS in COPD [Phase 2]

View source ↗

Summary

Phase 2 trial results for BIBW 2948 BS in chronic obstructive pulmonary disease and chronic bronchitis have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BIBW 2948 BS

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2021-11-19